

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | plasma membrane repair (GO:0001778) | 4.35902067 |
| 2 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.31172197 |
| 3 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.10224660 |
| 4 | cell adhesion mediated by integrin (GO:0033627) | 4.03627370 |
| 5 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.01384593 |
| 6 | sarcomere organization (GO:0045214) | 3.98551939 |
| 7 | tricarboxylic acid cycle (GO:0006099) | 3.98397995 |
| 8 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.95588027 |
| 9 | lysine metabolic process (GO:0006553) | 3.84041980 |
| 10 | lysine catabolic process (GO:0006554) | 3.84041980 |
| 11 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.82320448 |
| 12 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.79296698 |
| 13 | skin morphogenesis (GO:0043589) | 3.75296172 |
| 14 | cell communication involved in cardiac conduction (GO:0086065) | 3.74751649 |
| 15 | cell communication by electrical coupling (GO:0010644) | 3.71044736 |
| 16 | cardiac myofibril assembly (GO:0055003) | 3.67544354 |
| 17 | NADH metabolic process (GO:0006734) | 3.57545063 |
| 18 | carnitine shuttle (GO:0006853) | 3.46809087 |
| 19 | aspartate family amino acid catabolic process (GO:0009068) | 3.40930715 |
| 20 | regulation of hippo signaling (GO:0035330) | 3.40831466 |
| 21 | 2-oxoglutarate metabolic process (GO:0006103) | 3.35949022 |
| 22 | endodermal cell differentiation (GO:0035987) | 3.34290152 |
| 23 | regulation of early endosome to late endosome transport (GO:2000641) | 3.32882590 |
| 24 | barbed-end actin filament capping (GO:0051016) | 3.32256936 |
| 25 | positive regulation of osteoblast proliferation (GO:0033690) | 3.25259219 |
| 26 | cardiac muscle contraction (GO:0060048) | 3.23215103 |
| 27 | basement membrane organization (GO:0071711) | 3.17794881 |
| 28 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.17780470 |
| 29 | amino-acid betaine transport (GO:0015838) | 3.13091469 |
| 30 | carnitine transport (GO:0015879) | 3.13091469 |
| 31 | fatty acid transmembrane transport (GO:1902001) | 3.12305080 |
| 32 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.12042218 |
| 33 | sodium ion export (GO:0071436) | 3.08765709 |
| 34 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.06847216 |
| 35 | regulation of cardioblast differentiation (GO:0051890) | 3.06624990 |
| 36 | tricarboxylic acid metabolic process (GO:0072350) | 3.06291156 |
| 37 | COPI coating of Golgi vesicle (GO:0048205) | 3.05551302 |
| 38 | Golgi transport vesicle coating (GO:0048200) | 3.05551302 |
| 39 | endothelial cell chemotaxis (GO:0035767) | 3.05222481 |
| 40 | positive regulation of receptor recycling (GO:0001921) | 3.04336445 |
| 41 | heart trabecula formation (GO:0060347) | 3.01921344 |
| 42 | carnitine transmembrane transport (GO:1902603) | 3.00782960 |
| 43 | regulation of cholesterol homeostasis (GO:2000188) | 2.98080710 |
| 44 | low-density lipoprotein particle clearance (GO:0034383) | 2.95848042 |
| 45 | cardiac muscle cell development (GO:0055013) | 2.94899659 |
| 46 | regulation of tight junction assembly (GO:2000810) | 2.92790894 |
| 47 | response to magnesium ion (GO:0032026) | 2.91852606 |
| 48 | negative regulation of fatty acid transport (GO:2000192) | 2.89283937 |
| 49 | regulation of fatty acid oxidation (GO:0046320) | 2.88720702 |
| 50 | mannose metabolic process (GO:0006013) | 2.87678896 |
| 51 | biotin metabolic process (GO:0006768) | 2.87623373 |
| 52 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.86651738 |
| 53 | 4-hydroxyproline metabolic process (GO:0019471) | 2.85788126 |
| 54 | adhesion of symbiont to host (GO:0044406) | 2.85521322 |
| 55 | myofibril assembly (GO:0030239) | 2.85472001 |
| 56 | wound healing, spreading of epidermal cells (GO:0035313) | 2.84470028 |
| 57 | semaphorin-plexin signaling pathway (GO:0071526) | 2.83768941 |
| 58 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.83706234 |
| 59 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.82523322 |
| 60 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.82059200 |
| 61 | adhesion of symbiont to host cell (GO:0044650) | 2.81912336 |
| 62 | virion attachment to host cell (GO:0019062) | 2.81912336 |
| 63 | fatty acid beta-oxidation (GO:0006635) | 2.81443665 |
| 64 | regulation of membrane repolarization (GO:0060306) | 2.81107431 |
| 65 | cardiac muscle cell action potential (GO:0086001) | 2.80842834 |
| 66 | positive regulation of extracellular matrix organization (GO:1903055) | 2.80431112 |
| 67 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.79961517 |
| 68 | cell-substrate adherens junction assembly (GO:0007045) | 2.79878250 |
| 69 | focal adhesion assembly (GO:0048041) | 2.79878250 |
| 70 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.77441280 |
| 71 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.76052244 |
| 72 | cardiac cell development (GO:0055006) | 2.75633325 |
| 73 | hyaluronan catabolic process (GO:0030214) | 2.74240929 |
| 74 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.74105713 |
| 75 | negative regulation of cell size (GO:0045792) | 2.69515021 |
| 76 | protein retention in ER lumen (GO:0006621) | 2.69405214 |
| 77 | response to thyroid hormone (GO:0097066) | 2.69324481 |
| 78 | actomyosin structure organization (GO:0031032) | 2.69248945 |
| 79 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.67937678 |
| 80 | glomerular visceral epithelial cell development (GO:0072015) | 2.65851944 |
| 81 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.65323290 |
| 82 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.64791272 |
| 83 | collagen metabolic process (GO:0032963) | 2.64777292 |
| 84 | quaternary ammonium group transport (GO:0015697) | 2.64191962 |
| 85 | actin filament depolymerization (GO:0030042) | 2.63501785 |
| 86 | surfactant homeostasis (GO:0043129) | 2.63149901 |
| 87 | atrioventricular valve morphogenesis (GO:0003181) | 2.63148825 |
| 88 | positive regulation of sodium ion transport (GO:0010765) | 2.62860429 |
| 89 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.62194926 |
| 90 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.60908106 |
| 91 | glomerular basement membrane development (GO:0032836) | 2.60794949 |
| 92 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.60487723 |
| 93 | phosphate ion transport (GO:0006817) | 2.60242697 |
| 94 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.59348634 |
| 95 | apoptotic cell clearance (GO:0043277) | 2.58309358 |
| 96 | peptidyl-proline hydroxylation (GO:0019511) | 2.58234026 |
| 97 | glial cell migration (GO:0008347) | 2.55641482 |
| 98 | protein localization to endosome (GO:0036010) | 2.55126333 |
| 99 | regulation of actin filament-based movement (GO:1903115) | 2.55090445 |
| 100 | collagen catabolic process (GO:0030574) | 2.54838793 |
| 101 | phosphate ion transmembrane transport (GO:0035435) | 2.54823638 |
| 102 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.54762721 |
| 103 | activation of Rac GTPase activity (GO:0032863) | 2.54574418 |
| 104 | glycosphingolipid catabolic process (GO:0046479) | 2.53976866 |
| 105 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.53523559 |
| 106 | pinocytosis (GO:0006907) | 2.52642212 |
| 107 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.51444351 |
| 108 | mesodermal cell differentiation (GO:0048333) | 2.51389881 |
| 109 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.50907835 |
| 110 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.50514026 |
| 111 | endothelial cell morphogenesis (GO:0001886) | 2.50256084 |
| 112 | response to laminar fluid shear stress (GO:0034616) | 2.50184853 |
| 113 | protein hydroxylation (GO:0018126) | 2.49817017 |
| 114 | response to mercury ion (GO:0046689) | 2.47362633 |
| 115 | fatty acid catabolic process (GO:0009062) | 2.46068020 |
| 116 | amino-acid betaine metabolic process (GO:0006577) | 2.45709646 |
| 117 | endocytic recycling (GO:0032456) | 2.45638115 |
| 118 | alanine transport (GO:0032328) | 2.45628757 |
| 119 | substrate-dependent cell migration (GO:0006929) | 2.45532673 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 2.45517779 |
| 121 | multicellular organismal metabolic process (GO:0044236) | 2.43754730 |
| 122 | multicellular organismal catabolic process (GO:0044243) | 2.43654274 |
| 123 | cell-substrate junction assembly (GO:0007044) | 2.43516551 |
| 124 | membrane repolarization during action potential (GO:0086011) | 2.43191742 |
| 125 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.42762515 |
| 126 | extracellular matrix disassembly (GO:0022617) | 2.42731883 |
| 127 | stress fiber assembly (GO:0043149) | 2.42556358 |
| 128 | hemidesmosome assembly (GO:0031581) | 2.42089659 |
| 129 | fatty acid oxidation (GO:0019395) | 2.41992152 |
| 130 | alpha-linolenic acid metabolic process (GO:0036109) | 2.41963112 |
| 131 | lipid oxidation (GO:0034440) | 2.41719125 |
| 132 | regulation of the force of heart contraction (GO:0002026) | 2.41613576 |
| 133 | lung epithelium development (GO:0060428) | 2.40784505 |
| 134 | potassium ion import (GO:0010107) | 2.40583511 |
| 135 | cardiac muscle hypertrophy (GO:0003300) | 2.40482348 |
| 136 | short-chain fatty acid metabolic process (GO:0046459) | 2.40130633 |
| 137 | decidualization (GO:0046697) | 2.38270121 |
| 138 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.38136192 |
| 139 | fatty acid homeostasis (GO:0055089) | 2.37392759 |
| 140 | growth hormone secretion (GO:0030252) | 2.37358612 |
| 141 | * epithelial cell-cell adhesion (GO:0090136) | 2.36906585 |
| 142 | wound healing, spreading of cells (GO:0044319) | 2.36472254 |
| 143 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.36093505 |
| 144 | adherens junction assembly (GO:0034333) | 2.33809038 |
| 145 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.33246833 |
| 146 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.32932345 |
| 147 | regulation of integrin activation (GO:0033623) | 2.32845404 |
| 148 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.32583732 |
| 149 | desmosome organization (GO:0002934) | 2.32517105 |
| 150 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.32252690 |
| 151 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.31853011 |
| 152 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.31770522 |
| 153 | response to parathyroid hormone (GO:0071107) | 2.30883716 |
| 154 | glycolipid catabolic process (GO:0019377) | 2.30240313 |
| 155 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.30198770 |
| 156 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.29735571 |
| 157 | striated muscle hypertrophy (GO:0014897) | 2.29649807 |
| 158 | carnitine metabolic process (GO:0009437) | 2.29590730 |
| 159 | cell volume homeostasis (GO:0006884) | 2.29140535 |
| 160 | cysteine metabolic process (GO:0006534) | 2.28979953 |
| 161 | regulation of p38MAPK cascade (GO:1900744) | 2.28404738 |
| 162 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.28366597 |
| 163 | regulation of cofactor metabolic process (GO:0051193) | 2.27867955 |
| 164 | regulation of coenzyme metabolic process (GO:0051196) | 2.27867955 |
| 165 | hypotonic response (GO:0006971) | 2.27801338 |
| 166 | glomerular epithelial cell development (GO:0072310) | 2.27344613 |
| 167 | cellular modified amino acid catabolic process (GO:0042219) | 2.27104961 |
| 168 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.26784181 |
| 169 | protein heterotrimerization (GO:0070208) | 2.26212038 |
| 170 | negative regulation of focal adhesion assembly (GO:0051895) | 2.25164629 |
| 171 | negative regulation of cell junction assembly (GO:1901889) | 2.25164629 |
| 172 | negative regulation of adherens junction organization (GO:1903392) | 2.25164629 |
| 173 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.24452779 |
| 174 | negative regulation of protein localization to cell surface (GO:2000009) | 2.23552467 |
| 175 | macroautophagy (GO:0016236) | 2.23397054 |
| 176 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.22172425 |
| 177 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.21941299 |
| 178 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.21373721 |
| 179 | protein carboxylation (GO:0018214) | 2.21373721 |
| 180 | sphingosine metabolic process (GO:0006670) | 2.21001052 |
| 181 | positive regulation of p38MAPK cascade (GO:1900745) | 2.19513261 |
| 182 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.17647521 |
| 183 | membrane protein ectodomain proteolysis (GO:0006509) | 2.17330773 |
| 184 | angiogenesis involved in wound healing (GO:0060055) | 2.15867788 |
| 185 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.15648497 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.88879860 |
| 2 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.24135653 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.11777863 |
| 4 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.97530245 |
| 5 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.67240318 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.63844514 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.43156980 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.38132839 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.37031640 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.32402888 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.31545425 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.23420072 |
| 13 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20959465 |
| 14 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.19045996 |
| 15 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15553939 |
| 16 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.00446396 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.98317771 |
| 18 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.88484436 |
| 19 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.88484436 |
| 20 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.86743597 |
| 21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.83914402 |
| 22 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.81539840 |
| 23 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.80285799 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.79908779 |
| 25 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.74601075 |
| 26 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.71537141 |
| 27 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.71537141 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.68270393 |
| 29 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.67918394 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.64175079 |
| 31 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.63662766 |
| 32 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56198095 |
| 33 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55388172 |
| 34 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55343829 |
| 35 | KDM2B_26808549_Chip-Seq_K562_Human | 1.55016181 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.54359306 |
| 37 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.52352799 |
| 38 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50502022 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49921506 |
| 40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47954006 |
| 41 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.47579200 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.47147108 |
| 43 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.44201062 |
| 44 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43255128 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42247060 |
| 46 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.41892844 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.41341742 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37354313 |
| 49 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.37109256 |
| 50 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.35776829 |
| 51 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.35731975 |
| 52 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.34983967 |
| 53 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32480679 |
| 54 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.31526880 |
| 55 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.31131730 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.29979561 |
| 57 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.28883362 |
| 58 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.27153930 |
| 59 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.25228739 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25119050 |
| 61 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24830509 |
| 62 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.24347987 |
| 63 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.23657383 |
| 64 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23520825 |
| 65 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.23367898 |
| 66 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.23168188 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.23106706 |
| 68 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.21197169 |
| 69 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21149891 |
| 70 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20385326 |
| 71 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.17672065 |
| 72 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16237373 |
| 73 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.15519744 |
| 74 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15491458 |
| 75 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14161917 |
| 76 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.12900499 |
| 77 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.12468984 |
| 78 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12066416 |
| 79 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.12019947 |
| 80 | P68_20966046_ChIP-Seq_HELA_Human | 1.11217091 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10720252 |
| 82 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.09985581 |
| 83 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.09322571 |
| 84 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08480068 |
| 85 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.08106270 |
| 86 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06850295 |
| 87 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.06575411 |
| 88 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06522552 |
| 89 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06264469 |
| 90 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.06067246 |
| 91 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05967114 |
| 92 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04523121 |
| 93 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03306509 |
| 94 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.03163902 |
| 95 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03063453 |
| 96 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.02842292 |
| 97 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02841267 |
| 98 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.02320164 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01753915 |
| 100 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01209212 |
| 101 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.00511994 |
| 102 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00028344 |
| 103 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.99956897 |
| 104 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99708559 |
| 105 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.99257560 |
| 106 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.99058106 |
| 107 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99013192 |
| 108 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.98759929 |
| 109 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98751903 |
| 110 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.98292673 |
| 111 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.98247134 |
| 112 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.98218183 |
| 113 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97473504 |
| 114 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.96944144 |
| 115 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96350922 |
| 116 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.95388689 |
| 117 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.95222604 |
| 118 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94717368 |
| 119 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93479333 |
| 120 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.93359912 |
| 121 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93308259 |
| 122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93090155 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.92777202 |
| 124 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92523509 |
| 125 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91508005 |
| 126 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.90803705 |
| 127 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.90803705 |
| 128 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.90800358 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90082071 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89591626 |
| 131 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89394966 |
| 132 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.89201708 |
| 133 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.89125788 |
| 134 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87471435 |
| 135 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.87398012 |
| 136 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.87260439 |
| 137 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.87134011 |
| 138 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86644165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.75033220 |
| 2 | MP0004084_abnormal_cardiac_muscle | 3.68935137 |
| 3 | MP0000751_myopathy | 3.29128732 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.28964009 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.12353360 |
| 6 | MP0003646_muscle_fatigue | 2.97982035 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 2.83037697 |
| 8 | MP0005257_abnormal_intraocular_pressure | 2.72945877 |
| 9 | MP0004215_abnormal_myocardial_fiber | 2.51970071 |
| 10 | MP0002877_abnormal_melanocyte_morpholog | 2.40036449 |
| 11 | MP0005330_cardiomyopathy | 2.36936429 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.35820323 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.30605887 |
| 14 | MP0003453_abnormal_keratinocyte_physiol | 2.13861000 |
| 15 | MP0005023_abnormal_wound_healing | 2.09838715 |
| 16 | MP0003252_abnormal_bile_duct | 2.08428252 |
| 17 | MP0000750_abnormal_muscle_regeneration | 1.98763058 |
| 18 | MP0004130_abnormal_muscle_cell | 1.98304151 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 1.92543921 |
| 20 | MP0006138_congestive_heart_failure | 1.90149109 |
| 21 | MP0002972_abnormal_cardiac_muscle | 1.85945880 |
| 22 | MP0004087_abnormal_muscle_fiber | 1.85800691 |
| 23 | MP0003329_amyloid_beta_deposits | 1.85073273 |
| 24 | MP0004272_abnormal_basement_membrane | 1.83702165 |
| 25 | MP0009840_abnormal_foam_cell | 1.82221852 |
| 26 | MP0004510_myositis | 1.81963478 |
| 27 | MP0002269_muscular_atrophy | 1.79698438 |
| 28 | MP0003283_abnormal_digestive_organ | 1.78350545 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.77426892 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.72021371 |
| 31 | MP0003137_abnormal_impulse_conducting | 1.66745034 |
| 32 | MP0005451_abnormal_body_composition | 1.66652135 |
| 33 | MP0005360_urolithiasis | 1.65420235 |
| 34 | MP0006054_spinal_hemorrhage | 1.64341573 |
| 35 | MP0008775_abnormal_heart_ventricle | 1.63769938 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.63623578 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.62357588 |
| 38 | MP0005670_abnormal_white_adipose | 1.61305691 |
| 39 | MP0003566_abnormal_cell_adhesion | 1.60856432 |
| 40 | MP0005409_darkened_coat_color | 1.60761429 |
| 41 | MP0004043_abnormal_pH_regulation | 1.60303161 |
| 42 | MP0010630_abnormal_cardiac_muscle | 1.60087107 |
| 43 | MP0005332_abnormal_amino_acid | 1.59843310 |
| 44 | MP0001544_abnormal_cardiovascular_syste | 1.59767466 |
| 45 | MP0005385_cardiovascular_system_phenoty | 1.59767466 |
| 46 | MP0000749_muscle_degeneration | 1.58602963 |
| 47 | MP0004233_abnormal_muscle_weight | 1.56988534 |
| 48 | MP0005076_abnormal_cell_differentiation | 1.56508621 |
| 49 | MP0005620_abnormal_muscle_contractility | 1.55367831 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.55158385 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.54990952 |
| 52 | MP0009278_abnormal_bone_marrow | 1.52201310 |
| 53 | MP0001958_emphysema | 1.51965919 |
| 54 | MP0000858_altered_metastatic_potential | 1.51479909 |
| 55 | MP0000343_altered_response_to | 1.46452822 |
| 56 | MP0002060_abnormal_skin_morphology | 1.44930388 |
| 57 | MP0002928_abnormal_bile_duct | 1.44857976 |
| 58 | MP0000747_muscle_weakness | 1.44424651 |
| 59 | MP0005595_abnormal_vascular_smooth | 1.43342641 |
| 60 | MP0010368_abnormal_lymphatic_system | 1.40875682 |
| 61 | MP0005365_abnormal_bile_salt | 1.40062121 |
| 62 | MP0005083_abnormal_biliary_tract | 1.39752048 |
| 63 | MP0000678_abnormal_parathyroid_gland | 1.38185973 |
| 64 | MP0004484_altered_response_of | 1.35641607 |
| 65 | MP0000013_abnormal_adipose_tissue | 1.35555072 |
| 66 | MP0004085_abnormal_heartbeat | 1.35443236 |
| 67 | MP0003300_gastrointestinal_ulcer | 1.35039293 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.34770767 |
| 69 | MP0003045_fibrosis | 1.34532659 |
| 70 | MP0005275_abnormal_skin_tensile | 1.32009922 |
| 71 | MP0000767_abnormal_smooth_muscle | 1.32006993 |
| 72 | MP0003195_calcinosis | 1.30466387 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 1.29769265 |
| 74 | MP0005375_adipose_tissue_phenotype | 1.28840359 |
| 75 | MP0004185_abnormal_adipocyte_glucose | 1.28697682 |
| 76 | MP0004858_abnormal_nervous_system | 1.26381299 |
| 77 | MP0008961_abnormal_basal_metabolism | 1.22778646 |
| 78 | MP0003279_aneurysm | 1.21301499 |
| 79 | MP0005085_abnormal_gallbladder_physiolo | 1.19433019 |
| 80 | MP0003879_abnormal_hair_cell | 1.18967830 |
| 81 | MP0006082_CNS_inflammation | 1.16923745 |
| 82 | MP0001348_abnormal_lacrimal_gland | 1.16870820 |
| 83 | MP0008438_abnormal_cutaneous_collagen | 1.16103210 |
| 84 | MP0001756_abnormal_urination | 1.14857373 |
| 85 | MP0001666_abnormal_nutrient_absorption | 1.14840382 |
| 86 | MP0009643_abnormal_urine_homeostasis | 1.13131543 |
| 87 | MP0005164_abnormal_response_to | 1.13120943 |
| 88 | MP0004947_skin_inflammation | 1.12659052 |
| 89 | MP0002106_abnormal_muscle_physiology | 1.12187852 |
| 90 | MP0003075_altered_response_to | 1.12151558 |
| 91 | MP0002796_impaired_skin_barrier | 1.12140167 |
| 92 | MP0004885_abnormal_endolymph | 1.12078845 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 1.11013105 |
| 94 | MP0003878_abnormal_ear_physiology | 1.10415211 |
| 95 | MP0005377_hearing/vestibular/ear_phenot | 1.10415211 |
| 96 | MP0010352_gastrointestinal_tract_polyps | 1.09431167 |
| 97 | MP0005503_abnormal_tendon_morphology | 1.09142345 |
| 98 | MP0005165_increased_susceptibility_to | 1.08550898 |
| 99 | MP0008260_abnormal_autophagy | 1.05757875 |
| 100 | MP0000003_abnormal_adipose_tissue | 1.03624235 |
| 101 | MP0002234_abnormal_pharynx_morphology | 1.02564734 |
| 102 | MP0010329_abnormal_lipoprotein_level | 1.01736374 |
| 103 | MP0001765_abnormal_ion_homeostasis | 1.01652263 |
| 104 | MP0005464_abnormal_platelet_physiology | 1.00753250 |
| 105 | MP0009384_cardiac_valve_regurgitation | 1.00513942 |
| 106 | MP0003191_abnormal_cellular_cholesterol | 0.98564378 |
| 107 | MP0002118_abnormal_lipid_homeostasis | 0.97932379 |
| 108 | MP0005501_abnormal_skin_physiology | 0.95553224 |
| 109 | MP0002168_other_aberrant_phenotype | 0.94955311 |
| 110 | MP0005369_muscle_phenotype | 0.93399060 |
| 111 | MP0000759_abnormal_skeletal_muscle | 0.92998582 |
| 112 | MP0002127_abnormal_cardiovascular_syste | 0.92322533 |
| 113 | MP0000733_abnormal_muscle_development | 0.92277808 |
| 114 | MP0003221_abnormal_cardiomyocyte_apopto | 0.91597661 |
| 115 | MP0004859_abnormal_synaptic_plasticity | 0.91104366 |
| 116 | MP0001915_intracranial_hemorrhage | 0.89616051 |
| 117 | MP0004019_abnormal_vitamin_homeostasis | 0.89314255 |
| 118 | MP0003634_abnormal_glial_cell | 0.86776600 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.86119969 |
| 120 | MP0004782_abnormal_surfactant_physiolog | 0.85413808 |
| 121 | MP0002295_abnormal_pulmonary_circulatio | 0.84471475 |
| 122 | MP0001243_abnormal_dermal_layer | 0.83667401 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.83586879 |
| 124 | MP0003448_altered_tumor_morphology | 0.82960673 |
| 125 | MP0000604_amyloidosis | 0.82858381 |
| 126 | MP0001849_ear_inflammation | 0.82471162 |
| 127 | MP0000579_abnormal_nail_morphology | 0.82464310 |
| 128 | MP0001533_abnormal_skeleton_physiology | 0.82419318 |
| 129 | MP0002332_abnormal_exercise_endurance | 0.81938932 |
| 130 | MP0005508_abnormal_skeleton_morphology | 0.81921055 |
| 131 | MP0003183_abnormal_peptide_metabolism | 0.81523190 |
| 132 | MP0000249_abnormal_blood_vessel | 0.80594771 |
| 133 | MP0000681_abnormal_thyroid_gland | 0.80477265 |
| 134 | MP0002896_abnormal_bone_mineralization | 0.78890613 |
| 135 | MP0003656_abnormal_erythrocyte_physiolo | 0.77434113 |
| 136 | MP0003436_decreased_susceptibility_to | 0.77309729 |
| 137 | MP0005397_hematopoietic_system_phenotyp | 0.77124812 |
| 138 | MP0001545_abnormal_hematopoietic_system | 0.77124812 |
| 139 | MP0000266_abnormal_heart_morphology | 0.76185824 |
| 140 | MP0005171_absent_coat_pigmentation | 0.75088720 |
| 141 | MP0005319_abnormal_enzyme/_coenzyme | 0.74959256 |
| 142 | MP0010771_integument_phenotype | 0.74931560 |
| 143 | MP0009053_abnormal_anal_canal | 0.73922809 |
| 144 | MP0001661_extended_life_span | 0.73618372 |
| 145 | MP0003828_pulmonary_edema | 0.72760835 |
| 146 | MP0000920_abnormal_myelination | 0.72598961 |
| 147 | MP0005197_abnormal_uvea_morphology | 0.72457787 |
| 148 | MP0000537_abnormal_urethra_morphology | 0.72364657 |
| 149 | MP0010030_abnormal_orbit_morphology | 0.71954886 |
| 150 | MP0006036_abnormal_mitochondrial_physio | 0.69671707 |
| 151 | MP0001614_abnormal_blood_vessel | 0.69629110 |
| 152 | MP0005220_abnormal_exocrine_pancreas | 0.68831028 |
| 153 | MP0002078_abnormal_glucose_homeostasis | 0.67356768 |
| 154 | MP0003950_abnormal_plasma_membrane | 0.67251342 |
| 155 | MP0003690_abnormal_glial_cell | 0.66876918 |
| 156 | MP0005187_abnormal_penis_morphology | 0.65597244 |
| 157 | MP0003091_abnormal_cell_migration | 0.65189329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gout (HP:0001997) | 4.69254656 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 4.41055050 |
| 3 | Sudden death (HP:0001699) | 4.39060414 |
| 4 | Muscle fiber splitting (HP:0003555) | 4.15221732 |
| 5 | Bundle branch block (HP:0011710) | 4.01771741 |
| 6 | Ventricular tachycardia (HP:0004756) | 3.97609387 |
| 7 | Ventricular fibrillation (HP:0001663) | 3.64652370 |
| 8 | Atrophic scars (HP:0001075) | 3.27553814 |
| 9 | Abnormality of glycolipid metabolism (HP:0010969) | 3.26950665 |
| 10 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.26950665 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.26950665 |
| 12 | Hyperglycinuria (HP:0003108) | 3.26426559 |
| 13 | Atrioventricular block (HP:0001678) | 3.25817087 |
| 14 | Syncope (HP:0001279) | 3.24773604 |
| 15 | Ketoacidosis (HP:0001993) | 3.23238475 |
| 16 | Hyporeflexia of lower limbs (HP:0002600) | 3.20950990 |
| 17 | Increased connective tissue (HP:0009025) | 3.19389379 |
| 18 | Vertebral compression fractures (HP:0002953) | 3.15941965 |
| 19 | Ventricular arrhythmia (HP:0004308) | 3.03022368 |
| 20 | Atrial fibrillation (HP:0005110) | 3.01439783 |
| 21 | Heart block (HP:0012722) | 3.01035029 |
| 22 | Myoglobinuria (HP:0002913) | 3.00867467 |
| 23 | Difficulty climbing stairs (HP:0003551) | 3.00248579 |
| 24 | Exercise-induced myalgia (HP:0003738) | 3.00095023 |
| 25 | Neurofibrillary tangles (HP:0002185) | 2.99357455 |
| 26 | Abnormal atrioventricular conduction (HP:0005150) | 2.95324712 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 2.91724041 |
| 28 | Dysostosis multiplex (HP:0000943) | 2.91417324 |
| 29 | Distal lower limb amyotrophy (HP:0008944) | 2.90779606 |
| 30 | Neonatal death (HP:0003811) | 2.84159644 |
| 31 | Ulnar bowing (HP:0003031) | 2.83254806 |
| 32 | Fragile skin (HP:0001030) | 2.81912257 |
| 33 | Primary atrial arrhythmia (HP:0001692) | 2.81865582 |
| 34 | Exercise-induced muscle cramps (HP:0003710) | 2.80040273 |
| 35 | Nuclear cataract (HP:0100018) | 2.77935083 |
| 36 | Cervical subluxation (HP:0003308) | 2.77181349 |
| 37 | Cerebral aneurysm (HP:0004944) | 2.76939479 |
| 38 | Broad face (HP:0000283) | 2.76469967 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.75260952 |
| 40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.75260952 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.75260952 |
| 42 | Myocardial infarction (HP:0001658) | 2.74487120 |
| 43 | Mucopolysacchariduria (HP:0008155) | 2.73460121 |
| 44 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.73460121 |
| 45 | Abnormality of glycine metabolism (HP:0010895) | 2.72276614 |
| 46 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.72276614 |
| 47 | Potter facies (HP:0002009) | 2.71196091 |
| 48 | Facial shape deformation (HP:0011334) | 2.71196091 |
| 49 | Supraventricular arrhythmia (HP:0005115) | 2.71164473 |
| 50 | Difficulty running (HP:0009046) | 2.69448090 |
| 51 | Hypoglycemic coma (HP:0001325) | 2.67722537 |
| 52 | Achilles tendon contracture (HP:0001771) | 2.64152470 |
| 53 | Supraventricular tachycardia (HP:0004755) | 2.63754290 |
| 54 | Thin bony cortex (HP:0002753) | 2.60822962 |
| 55 | Increased cerebral lipofuscin (HP:0011813) | 2.59499735 |
| 56 | Hyperuricemia (HP:0002149) | 2.59399958 |
| 57 | Increased purine levels (HP:0004368) | 2.59399958 |
| 58 | Ketosis (HP:0001946) | 2.57575568 |
| 59 | Arterial tortuosity (HP:0005116) | 2.54409695 |
| 60 | Wormian bones (HP:0002645) | 2.53422650 |
| 61 | Prolonged QT interval (HP:0001657) | 2.51992181 |
| 62 | Abnormality of the calf musculature (HP:0001430) | 2.50851929 |
| 63 | Interstitial pulmonary disease (HP:0006530) | 2.50441281 |
| 64 | Shallow orbits (HP:0000586) | 2.49251988 |
| 65 | Natal tooth (HP:0000695) | 2.49101095 |
| 66 | Abnormality of the Achilles tendon (HP:0005109) | 2.48829263 |
| 67 | Palpitations (HP:0001962) | 2.48711310 |
| 68 | Aortic dissection (HP:0002647) | 2.48550850 |
| 69 | Vascular tortuosity (HP:0004948) | 2.48502954 |
| 70 | Axonal loss (HP:0003447) | 2.47753589 |
| 71 | Lipoatrophy (HP:0100578) | 2.46574482 |
| 72 | Osteolytic defects of the hand bones (HP:0009699) | 2.45628418 |
| 73 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45628418 |
| 74 | Spinal rigidity (HP:0003306) | 2.44575740 |
| 75 | Lymphangioma (HP:0100764) | 2.42384320 |
| 76 | Broad metatarsal (HP:0001783) | 2.39574139 |
| 77 | Aortic aneurysm (HP:0004942) | 2.39095851 |
| 78 | Hyperacusis (HP:0010780) | 2.38793857 |
| 79 | Mitral stenosis (HP:0001718) | 2.36212498 |
| 80 | Increased circulating renin level (HP:0000848) | 2.34010906 |
| 81 | Bronchomalacia (HP:0002780) | 2.32041453 |
| 82 | Premature rupture of membranes (HP:0001788) | 2.30736924 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.30122084 |
| 84 | Calf muscle hypertrophy (HP:0008981) | 2.28547006 |
| 85 | Elbow flexion contracture (HP:0002987) | 2.27851541 |
| 86 | Hyperglycinemia (HP:0002154) | 2.26490356 |
| 87 | J-shaped sella turcica (HP:0002680) | 2.25844573 |
| 88 | Late onset (HP:0003584) | 2.20316226 |
| 89 | Hyperglycemia (HP:0003074) | 2.19428640 |
| 90 | Focal segmental glomerulosclerosis (HP:0000097) | 2.19421968 |
| 91 | Bladder diverticulum (HP:0000015) | 2.17976179 |
| 92 | Blue sclerae (HP:0000592) | 2.17746938 |
| 93 | Upper limb amyotrophy (HP:0009129) | 2.16860272 |
| 94 | Distal upper limb amyotrophy (HP:0007149) | 2.16860272 |
| 95 | Esophageal varix (HP:0002040) | 2.14225276 |
| 96 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14152213 |
| 97 | Systemic lupus erythematosus (HP:0002725) | 2.12168150 |
| 98 | Abnormality of complement system (HP:0005339) | 2.11851906 |
| 99 | Joint stiffness (HP:0001387) | 2.09543619 |
| 100 | Turricephaly (HP:0000262) | 2.08883814 |
| 101 | Hypokalemic alkalosis (HP:0001949) | 2.07869805 |
| 102 | Dilated cardiomyopathy (HP:0001644) | 2.07456254 |
| 103 | Malnutrition (HP:0004395) | 2.07080804 |
| 104 | Mitral regurgitation (HP:0001653) | 2.06932520 |
| 105 | EMG: myopathic abnormalities (HP:0003458) | 2.06864691 |
| 106 | Polycythemia (HP:0001901) | 2.06428436 |
| 107 | Protrusio acetabuli (HP:0003179) | 2.06251554 |
| 108 | Hemorrhage of the eye (HP:0011885) | 2.04700097 |
| 109 | Stridor (HP:0010307) | 2.03808071 |
| 110 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.03755827 |
| 111 | Xanthomatosis (HP:0000991) | 2.03631645 |
| 112 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03587383 |
| 113 | Lower limb amyotrophy (HP:0007210) | 1.99285914 |
| 114 | Hyperammonemia (HP:0001987) | 1.98657468 |
| 115 | Abnormality of purine metabolism (HP:0004352) | 1.97391377 |
| 116 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.96985706 |
| 117 | Aplasia of the phalanges of the hand (HP:0009802) | 1.96985706 |
| 118 | Aplasia involving bones of the extremities (HP:0009825) | 1.96985706 |
| 119 | Spondylolisthesis (HP:0003302) | 1.96208668 |
| 120 | Hand muscle atrophy (HP:0009130) | 1.94962029 |
| 121 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.93964555 |
| 122 | Aneurysm (HP:0002617) | 1.93429055 |
| 123 | Menorrhagia (HP:0000132) | 1.92801193 |
| 124 | Athetosis (HP:0002305) | 1.90327632 |
| 125 | Abnormal EKG (HP:0003115) | 1.90120953 |
| 126 | Loss of speech (HP:0002371) | 1.89510264 |
| 127 | Enlarged penis (HP:0000040) | 1.88987306 |
| 128 | Visceral angiomatosis (HP:0100761) | 1.88459262 |
| 129 | Renal salt wasting (HP:0000127) | 1.88169484 |
| 130 | Follicular hyperkeratosis (HP:0007502) | 1.87892584 |
| 131 | Cardiovascular calcification (HP:0011915) | 1.87300103 |
| 132 | Thick nail (HP:0001805) | 1.86829432 |
| 133 | Complement deficiency (HP:0004431) | 1.86710882 |
| 134 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.86547440 |
| 135 | Aortic regurgitation (HP:0001659) | 1.84435261 |
| 136 | Hypoalphalipoproteinemia (HP:0003233) | 1.84156922 |
| 137 | Alopecia of scalp (HP:0002293) | 1.83560280 |
| 138 | Hamartoma of the eye (HP:0010568) | 1.83249692 |
| 139 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.82983110 |
| 140 | Abnormal urine output (HP:0012590) | 1.82010500 |
| 141 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.81126994 |
| 142 | Distal lower limb muscle weakness (HP:0009053) | 1.79530308 |
| 143 | Global brain atrophy (HP:0002283) | 1.78765715 |
| 144 | Short nail (HP:0001799) | 1.78667355 |
| 145 | Hydroxyprolinuria (HP:0003080) | 1.78110120 |
| 146 | Abnormality of proline metabolism (HP:0010907) | 1.78110120 |
| 147 | Dilatation of the ascending aorta (HP:0005111) | 1.77343728 |
| 148 | Soft skin (HP:0000977) | 1.76220115 |
| 149 | Increased mean platelet volume (HP:0011877) | 1.76022626 |
| 150 | Flat acetabular roof (HP:0003180) | 1.75217339 |
| 151 | Deep venous thrombosis (HP:0002625) | 1.74810337 |
| 152 | Increased variability in muscle fiber diameter (HP:0003557) | 1.74760277 |
| 153 | Vacuolated lymphocytes (HP:0001922) | 1.74613719 |
| 154 | Myotonia (HP:0002486) | 1.74387331 |
| 155 | Dicarboxylic aciduria (HP:0003215) | 1.74312223 |
| 156 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.74312223 |
| 157 | Rhabdomyolysis (HP:0003201) | 1.74257302 |
| 158 | Neonatal short-limb short stature (HP:0008921) | 1.74249246 |
| 159 | Glomerulosclerosis (HP:0000096) | 1.73702680 |
| 160 | Mitral valve prolapse (HP:0001634) | 1.73648024 |
| 161 | Abnormality of renal excretion (HP:0011036) | 1.73502374 |
| 162 | Hemangiomatosis (HP:0007461) | 1.72981055 |
| 163 | Cerebral inclusion bodies (HP:0100314) | 1.72713813 |
| 164 | Disproportionate tall stature (HP:0001519) | 1.72691882 |
| 165 | Limb-girdle muscle atrophy (HP:0003797) | 1.71751391 |
| 166 | Vascular calcification (HP:0004934) | 1.71485067 |
| 167 | Ankle contracture (HP:0006466) | 1.71364614 |
| 168 | Retinal atrophy (HP:0001105) | 1.70896429 |
| 169 | Abnormality of the acetabulum (HP:0003170) | 1.70775394 |
| 170 | Hyperactive renin-angiotensin system (HP:0000841) | 1.70374358 |
| 171 | Zonular cataract (HP:0010920) | 1.70336913 |
| 172 | Subaortic stenosis (HP:0001682) | 1.70228770 |
| 173 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.70228770 |
| 174 | Polyuria (HP:0000103) | 1.70001237 |
| 175 | Onion bulb formation (HP:0003383) | 1.69416504 |
| 176 | Advanced eruption of teeth (HP:0006288) | 1.68872567 |
| 177 | Abnormality of the lower motor neuron (HP:0002366) | 1.68430583 |
| 178 | Glomerulonephritis (HP:0000099) | 1.68404632 |
| 179 | Long toe (HP:0010511) | 1.66455031 |
| 180 | Rapidly progressive (HP:0003678) | 1.65670039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.54511299 |
| 2 | IRAK3 | 4.09242109 |
| 3 | LMTK2 | 3.36250522 |
| 4 | TTN | 3.30377469 |
| 5 | PDK3 | 2.92986310 |
| 6 | PDK4 | 2.92986310 |
| 7 | PKN2 | 2.62896740 |
| 8 | PHKG1 | 2.38479243 |
| 9 | PHKG2 | 2.38479243 |
| 10 | RIPK1 | 2.38294479 |
| 11 | EPHA2 | 2.31337165 |
| 12 | PRKD3 | 2.28586475 |
| 13 | NME2 | 2.22177615 |
| 14 | WNK4 | 2.05495975 |
| 15 | BCKDK | 1.94916669 |
| 16 | LATS2 | 1.87653822 |
| 17 | PDGFRA | 1.86897952 |
| 18 | NEK1 | 1.81327147 |
| 19 | PDK2 | 1.80013830 |
| 20 | MAP3K9 | 1.73266156 |
| 21 | TESK1 | 1.72231345 |
| 22 | STK38 | 1.70743625 |
| 23 | PAK3 | 1.58548278 |
| 24 | WNK3 | 1.50583380 |
| 25 | PTK6 | 1.46332504 |
| 26 | MAP3K6 | 1.46004464 |
| 27 | ERBB4 | 1.45597646 |
| 28 | TIE1 | 1.44763934 |
| 29 | FER | 1.38165379 |
| 30 | PIM2 | 1.37429033 |
| 31 | CDK12 | 1.34559819 |
| 32 | SIK1 | 1.33357139 |
| 33 | LATS1 | 1.31446215 |
| 34 | KSR2 | 1.30857518 |
| 35 | MOS | 1.28250864 |
| 36 | ERN1 | 1.26363341 |
| 37 | DDR2 | 1.25316778 |
| 38 | PINK1 | 1.24674724 |
| 39 | PRKG2 | 1.20142238 |
| 40 | NTRK1 | 1.17724944 |
| 41 | DMPK | 1.15788676 |
| 42 | PTK2 | 1.14982712 |
| 43 | PAK6 | 1.14782076 |
| 44 | MYLK | 1.14598665 |
| 45 | TAOK2 | 1.13211710 |
| 46 | ICK | 1.12571150 |
| 47 | FGFR4 | 1.12036490 |
| 48 | MAP2K3 | 1.10914730 |
| 49 | ZAP70 | 1.08972933 |
| 50 | ABL2 | 1.08835622 |
| 51 | STK38L | 0.98460239 |
| 52 | PRPF4B | 0.98019209 |
| 53 | EPHA4 | 0.97706698 |
| 54 | TRPM7 | 0.94569085 |
| 55 | PRKD1 | 0.94564084 |
| 56 | EPHB1 | 0.94280731 |
| 57 | MST1R | 0.92967749 |
| 58 | CAMKK1 | 0.91253135 |
| 59 | LIMK1 | 0.91046345 |
| 60 | RPS6KA2 | 0.90858592 |
| 61 | EEF2K | 0.89944959 |
| 62 | PAK4 | 0.88643070 |
| 63 | BMX | 0.88513184 |
| 64 | NEK9 | 0.84032303 |
| 65 | TAOK1 | 0.82965279 |
| 66 | MET | 0.80644350 |
| 67 | TYRO3 | 0.79875567 |
| 68 | MAPKAPK3 | 0.78515677 |
| 69 | PTK2B | 0.78496721 |
| 70 | TBK1 | 0.77782221 |
| 71 | PDPK1 | 0.77350035 |
| 72 | MAP3K11 | 0.76046240 |
| 73 | PRKAA1 | 0.75153374 |
| 74 | MAP2K1 | 0.74922869 |
| 75 | ARAF | 0.74347014 |
| 76 | ROCK1 | 0.73435372 |
| 77 | DAPK2 | 0.73130487 |
| 78 | MAPK11 | 0.71379736 |
| 79 | MTOR | 0.70841281 |
| 80 | RET | 0.70479344 |
| 81 | PRKCH | 0.68593060 |
| 82 | MAP3K13 | 0.68433920 |
| 83 | MAP3K2 | 0.67634576 |
| 84 | EPHB2 | 0.67112638 |
| 85 | CDC42BPA | 0.66996233 |
| 86 | MAP3K7 | 0.66754103 |
| 87 | MAPK15 | 0.66398755 |
| 88 | ALK | 0.64462087 |
| 89 | LRRK2 | 0.62971996 |
| 90 | FGFR1 | 0.62399412 |
| 91 | SMG1 | 0.61955012 |
| 92 | MARK1 | 0.61318174 |
| 93 | OXSR1 | 0.61312293 |
| 94 | FGFR2 | 0.59722050 |
| 95 | CAMK1G | 0.58672546 |
| 96 | PDGFRB | 0.57590899 |
| 97 | MUSK | 0.54875617 |
| 98 | DYRK1B | 0.54130674 |
| 99 | ILK | 0.54084247 |
| 100 | CAMK1D | 0.53732122 |
| 101 | MAP3K1 | 0.51910902 |
| 102 | PRKD2 | 0.50371287 |
| 103 | MAP3K14 | 0.49671410 |
| 104 | FLT3 | 0.49054516 |
| 105 | DAPK3 | 0.48583128 |
| 106 | MAPK12 | 0.48230096 |
| 107 | RPS6KC1 | 0.47841904 |
| 108 | RPS6KL1 | 0.47841904 |
| 109 | MAP3K3 | 0.47240111 |
| 110 | CAMK2D | 0.47202712 |
| 111 | GRK7 | 0.47119374 |
| 112 | INSRR | 0.47049208 |
| 113 | SGK3 | 0.44929220 |
| 114 | PRKAA2 | 0.44926359 |
| 115 | PAK2 | 0.44677246 |
| 116 | GSK3A | 0.42173990 |
| 117 | MAPK7 | 0.42117055 |
| 118 | MAP3K8 | 0.41776180 |
| 119 | PDK1 | 0.41645163 |
| 120 | KDR | 0.41163343 |
| 121 | ADRBK2 | 0.40580347 |
| 122 | WNK1 | 0.40578490 |
| 123 | CAMK2G | 0.40359674 |
| 124 | MAP2K4 | 0.39309004 |
| 125 | MARK2 | 0.38661443 |
| 126 | CAMK2B | 0.36785830 |
| 127 | STK39 | 0.36192555 |
| 128 | STK11 | 0.36077537 |
| 129 | MINK1 | 0.35814132 |
| 130 | PRKACG | 0.35324322 |
| 131 | PRKCI | 0.35248511 |
| 132 | RPS6KA6 | 0.34999271 |
| 133 | PRKCE | 0.34647093 |
| 134 | PRKCZ | 0.34548925 |
| 135 | TGFBR2 | 0.34472835 |
| 136 | MAP2K6 | 0.34122360 |
| 137 | MAP2K2 | 0.33114611 |
| 138 | STK10 | 0.32303405 |
| 139 | ROCK2 | 0.31879302 |
| 140 | MELK | 0.31814238 |
| 141 | CLK1 | 0.31794909 |
| 142 | ADRBK1 | 0.30729883 |
| 143 | NTRK3 | 0.29040772 |
| 144 | SIK2 | 0.27936819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.54447959 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.26536654 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.14184834 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 3.10080725 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.79198863 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61956750 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.57930469 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.31795152 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.24191931 |
| 10 | Lysosome_Homo sapiens_hsa04142 | 2.21594371 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.19914806 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.09238288 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.04248448 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.99492399 |
| 15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.89642581 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 1.81699757 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.77830835 |
| 18 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.77084601 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.69388395 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.68399004 |
| 21 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.63802059 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.62713360 |
| 23 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.55164907 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.46857686 |
| 25 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.45472488 |
| 26 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.44314437 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41311245 |
| 28 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.33405967 |
| 29 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.32790432 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30571911 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.29448552 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.27185366 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.25505509 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.24660691 |
| 35 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.19517257 |
| 36 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.17102448 |
| 37 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16405532 |
| 38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11709282 |
| 39 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.11396725 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.08895394 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.08277559 |
| 42 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.08193508 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.06894893 |
| 44 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03281731 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.01085832 |
| 46 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.98669263 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.97560607 |
| 48 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.96778890 |
| 49 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.96487313 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95356420 |
| 51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94690236 |
| 52 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.94363967 |
| 53 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92819758 |
| 54 | Focal adhesion_Homo sapiens_hsa04510 | 0.91839207 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 0.91420845 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.91059819 |
| 57 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.90465675 |
| 58 | Tight junction_Homo sapiens_hsa04530 | 0.90410783 |
| 59 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.90355069 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 0.89918106 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.89086912 |
| 62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.88684004 |
| 63 | Insulin secretion_Homo sapiens_hsa04911 | 0.87510452 |
| 64 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86298563 |
| 65 | Malaria_Homo sapiens_hsa05144 | 0.85394095 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.85278330 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.82926206 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80425572 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80101132 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80094049 |
| 71 | Lysine degradation_Homo sapiens_hsa00310 | 0.79093638 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78068900 |
| 73 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.78009936 |
| 74 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.77123397 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76962889 |
| 76 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.76271498 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75652517 |
| 78 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75068404 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73666829 |
| 80 | Peroxisome_Homo sapiens_hsa04146 | 0.72345075 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.71958677 |
| 82 | Adherens junction_Homo sapiens_hsa04520 | 0.71640598 |
| 83 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.71582428 |
| 84 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71204605 |
| 85 | Endocytosis_Homo sapiens_hsa04144 | 0.71170526 |
| 86 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.70918900 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70356372 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.70209035 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70078136 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69021649 |
| 91 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68450357 |
| 92 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.68411821 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66714226 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66659703 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66081243 |
| 96 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65375770 |
| 97 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65330103 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.64695296 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.64515497 |
| 100 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.64475455 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64247778 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.64135096 |
| 103 | Bladder cancer_Homo sapiens_hsa05219 | 0.64066141 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.62073813 |
| 105 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62012641 |
| 106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.61892929 |
| 107 | Salivary secretion_Homo sapiens_hsa04970 | 0.60957999 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.60900132 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60520725 |
| 110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.60188315 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59725478 |
| 112 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59351332 |
| 113 | Phagosome_Homo sapiens_hsa04145 | 0.58502542 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57485816 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.57169818 |
| 116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56502799 |
| 117 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.54635866 |
| 118 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53878640 |
| 119 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.52013293 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51467902 |
| 121 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51216948 |
| 122 | Gap junction_Homo sapiens_hsa04540 | 0.51200731 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49720321 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.49557361 |
| 125 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.48937700 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.48074773 |
| 127 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47538904 |
| 128 | Hepatitis C_Homo sapiens_hsa05160 | 0.47338308 |
| 129 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.47046500 |
| 130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.46756651 |
| 131 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46567771 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.45650260 |
| 133 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42918283 |
| 134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41899274 |
| 135 | Tuberculosis_Homo sapiens_hsa05152 | 0.41856622 |
| 136 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41483233 |
| 137 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.41288813 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.40937497 |
| 139 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40826082 |
| 140 | Renin secretion_Homo sapiens_hsa04924 | 0.40289411 |
| 141 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40075551 |
| 142 | Pathways in cancer_Homo sapiens_hsa05200 | 0.39363151 |
| 143 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39079229 |
| 144 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38746906 |
| 145 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.38464334 |
| 146 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.38061061 |
| 147 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37852191 |
| 148 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.37770433 |
| 149 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.37182726 |
| 150 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36933887 |
| 151 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.36191937 |
| 152 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.35316077 |
| 153 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.34981609 |
| 154 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34882962 |
| 155 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34865850 |
| 156 | Circadian entrainment_Homo sapiens_hsa04713 | 0.34063064 |

